PhaseOne Health Highlights Long-term Outcomes of Using Hypochlorous Acid at The Aesthetic Meeting 2024

HOCl effective in reducing recurrent capsular contracture in secondary cases over a 5 year follow up period. VANCOUVER, BC, April 29, 2024 /PRNewswire/ -- PhaseOne Health President and CEO Jeff Nugent announced the company's participation in The Aesthetic Meeting 2024 which is being held...

Apr 29, 2024 - 16:45
0

HOCl effective in reducing recurrent capsular contracture in secondary cases over a 5 year follow up period. VANCOUVER, BC, April 29, 2024 /PRNewswire/ -- PhaseOne Health President and CEO Jeff Nugent announced the company's participation in The Aesthetic Meeting 2024 which is being held...

Read More